冷療照護介入對癌症病人接受化學治療皮膚毒性反應之成效—系統性文獻回顧

The Effectiveness of Cooling Packaging Care in Relieving Chemotherapy-Induced Skin Toxicity Reactions in Cancer Patients Receiving Chemotherapy: A Systematic Review

10.6224/JN.000055

許雅惠(Ya-Hui Hsu)；洪幸薇(Hsing-Wei Hung)；陳淑卿(Shu-Ching Chen)

癌症病人 ； 化學治療 ； 冷療 ； 皮膚毒性反應 ； 系統性文獻回顧 ； cancer patients ； chemotherapy ； cooling packaging care ； skin toxicity reaction ； systematic review

護理雜誌

64卷4期（2017 / 08 / 01）

63 - 70

繁體中文

背景　抗癌化學治療會引起皮膚毒性反應，冷療照護種類對於化學治療皮膚毒性反應成效不一。目的　探討冷療照護介入，對於癌症病人接受化學治療引起皮膚毒性反應之成效。方法　以系統性文獻回顧法，使用「chermotherapy cutaneous toxicity」、「chemotherapy skin reaction 」、「chemotherapy skin toxicity」、「化學治療皮膚毒性」、「化學治療皮膚毒性反應」；「frozen glove」、「frozen sock」、「冷療」、「冰手套」、「冰襪」、「局部冰敷」；「usual care」、「常規照護」；「severity」、「comfort」、「satisfaction」、「嚴重度」、「舒適度」、「滿意度」等關鍵字搜尋資料庫，選取文獻符合篩選標準並排除重複文獻，共得五篇。結果　本系統性文獻回顧納入五篇隨機分派之實驗性研究，共222位有單獨或合併接受docetaxel（紫杉醇）及單獨接受PLD（pegylated liposomal doxorubicin）化學治療癌症病人。結果發現使用冷療介於-10℃– -30℃，皮膚毒性反應發生率有下降。但受限於研究樣本數小，且冷療介入方案不同、溫度、時間、頻率、持續時間有所不同，需更多研究進行探討。結論及臨床應用　整合文獻結果， 使用docetaxel or PLD的前15分鐘、輸液期間1小時及結束後15分鐘， 使用-25℃－ -30℃的Elasto-Gel冷凍襪或冷凍手套，可改善使皮膚毒性反應發生的頻率和嚴重程度。局部冷療為非藥物處置，其成本低及無副作用，可供未來臨床使用之參考。

Background: Anti-cancer chemotherapy may cause skin-toxicity reactions. Different types of cooling packages affect chemotherapy-induced skin toxicity reactions differently. Purpose: To evaluate the effects of cooling packing care on chemotherapy-induced skin toxicity reactions in cancer patients receiving chemotherapy. Methods: A systematic review approach was used. Searches were conducted in databases including Cochrane Library, Embase, MEDLINE, PubMed and Airiti Library using the keywords ＂chemotherapy cutaneous toxicity＂, ＂chemotherapy skin reaction＂, ＂chemotherapy skin toxicity＂, ＂frozen glove＂, ＂frozen sock＂, ＂cooling packaging care＂, ＂ice gloves＂, ＂ice socks＂, ＂usual care＂, ＂severity＂, ＂comfort＂, ＂satisfaction＂, ＂severity＂, and ＂comfort＂. The search focused on articles published before December 2016. Based on the inclusion and exclusion criteria, 5 articles involving relevant randomized controlled trials were extracted for review. Results: Elasto-Gel ice gloves or ice socks that were chilled to -25℃－ -30℃ and used for 15 mins during initial chemotherapy, for one hour during chemotherapy infusion, and for 15 mins after chemotherapy were shown to improve the frequency and severity of chemotherapy-induced skin toxicity reactions. Several studies were limited by small sample sizes and different types of cooling packing programs, temperature, timing, and frequency. Thus, further research is recommended to verify the effects of cooling packing care. Conclusions / Implications for Practice: Cancer patients who were treated with docetaxel or PLD and who used ice gloves or ice socks that were chilled to -25℃－ -30℃ for 15 mins during initial chemotherapy, for one hour during chemotherapy infusion, and for 15 mins after chemotherapy improved significantly in terms of the frequency and severity of their chemotherapy-induced skin toxicity reactions. Local cooling packing care is a non-pharmacotherapy approach that is low cost and free of side effects. This review is intended to provide a reference for clinical care.

1. 張黎露、朱家瑜、姜紹青、許麗珠、黃國埕、周文珊、侯秀香(2015)。標靶治療藥品之皮膚毒性預防及照護指引。腫瘤護理雜誌，15(增訂刊=15 Suppl.)，47-80。
   連結：
2. 衛生福利部國民健康署（2016）．癌症登記線上互動查詢系統． 取自https://cris.hpa.gov.tw/pagepub/Home.aspx[Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC. (2016). Cancer registry interactive on-line search system. Retrieved from https://cris.hpa.gov.tw/pagepub/Home.aspx
3. World Health Organization. (2017). Cancer-Fact sheet. Retrieved from http://www.who.int/mediacentre/factsheets/fs297/en/
4. U.S. Department of Health and Human Services, National Institutes of Health, & National Cancer Institute. (2009). Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0. Retrieved from http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
5. Can, G.,Aydiner, A.,Cavdar, I.(2012).Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.European Journal of Oncology Nursing,16(3),270-275.
6. Gomez, P.,Lacouture, M. E.(2011).Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: Experience in breast cancer.The Oncologist,16(11),1508-1519.
7. Ishiguro, H.,Takashima, S.,Yoshimura, K.,Yano, I.,Yamamoto, T.,Niimi, M.,Fukushima, M.(2012).Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients.Supportive Care in Cancer,20(9),2017-2024.
8. Kadakia, K. C.,Rozell, S. A.,Butala, A. A.,Loprinzi, C. L.(2014).Supportive cryotherapy: A review from head to toe.Journal of Pain and Symptom Management,47(6),1100-1115.
9. Mangili, G.,Petrone, M.,Gentile, C.,De Marzi, P.,Viganò, R.,Rabaiotti, E.(2008).Prevention strategies in palmar-plantar erythrodysesthesia onset: The role of regional cooling.Gynecologic Oncology,108(2),332-335.
10. McCarthy, A. L.,Shaban, R. Z.,Gillespie, K.,Vick, J.(2014).Cryotherapy for docetaxel-induced hand and nail toxicity: Randomised control trial.Supportive Care in Cancer,22(5),1375-1383.
11. Miller, K. K.,Gorcey, L.,McLellan, B. N.(2014).Chemotherapy-induced hand-foot syndrome and nail changes: A review of clinical presentation, etiology, pathogenesis, and management.Journal of the American Academy of Dermatology,71(4),787-794.
12. Nikolaou, V.,Syrigos, K.,Saif, M. W.(2016).Incidence and implications of chemotherapy related hand-foot syndrome.Expert Opinion on Drug Safety,15(12),1625-1633.
13. Olivo, S. A.,Macedo, L. G.,Gadotti, I. C.,Fuentes, J.,Stanton, T.,Magee, D. J.(2008).Scales to assess the quality of randomized controlled trials: A systematic review.Physical Therapy,88(2),156-175.
14. Oremus, M.,Wolfson, C.,Perrault, A.,Demers, L.,Momoli, F.,Moride, Y.(2001).Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials.Dementia and Geriatric Cognitive Disorders,12(3),232-236.
15. Payne, A. S.,James, W. D.,Weiss, R. B.(2006).Dermatologic toxicity of chemotherapeutic agents.Seminars in Oncology,33(1),86-97.
16. Scotté, F.,Banu, E.,Medioni, J.,Levy, E.,Ebenezer, C.,Marsan, S.,Oudard, S.(2008).Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.Cancer,112(7),1625-1631.
17. Scotté, F.,Tourani, J.-M.,Banu, E.,Peyromaure, M.,Levy, E.,Marsan, S.,Oudard, S.(2005).Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.Journal of Clinical Oncology,23(19),4424-4429.
18. Steckel, J.,Goethijn, F.,De Bruyne, G.,Nulens, V.,Lacko, D.,Bey, S.,Verwulgen, S.(2013).A research platform using active local cooling directed at minimizing the blood flow in human fingers.Revue Bénédictine,27(1-4),498-499.
19. Viale, P. H.(2006).Chemotherapy and cutaneous toxicities: Implications for oncology nurses.Seminars in Oncology Nursing,22(3),144-151.
20. von Moos, R.,Thuerlimann, B. J. K.,Aapro, M.,Rayson, D.,Harrold, K.,Sehouli, J.,Hauschild, A.(2008).Pegylated liposomal doxorubicin-associated hand-foot syndrome: Recommendations of an international panel of experts.European Journal of Cancer,44(6),781-790.

1. 駱宛瑩,陳柔蓁,郭惠貞,曹英(2022)。提升婦癌化學治療病人手足症候群護理指導完整率之專案。領導護理，23(4)，164-180。
2. 蕭雅群,鄭惠蘭,劉佩婷,孫婉綾,李淑慧(2023)。降低神經毒性化療藥物引起周邊神經病變改善專案。腫瘤護理雜誌，23(1)，53-68。
3. 楊婷婷,紀慧真(2021)。一位乳癌手術患者首次接受化學治療引起周邊神經病變之護理經驗。腫瘤護理雜誌，21(增訂刊II)，57-68。